Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001209191-24-001655

10% owner sold 4,235 shares at an average $0.85 ($3,600)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Atlas Venture Fund XI, L.P. 10% owner 2024-01-11 Sale −1,566 $0.87 $1,362 2,021,836 D
Atlas Venture Fund XI, L.P. 10% owner 2024-01-11 Sale −569 $0.87 $495 735,373 I
Atlas Venture Fund XI, L.P. 10% owner 2024-01-12 Sale −1,540 $0.83 $1,278 2,020,296 D
Atlas Venture Fund XI, L.P. 10% owner 2024-01-12 Sale −560 $0.83 $465 734,813 I
Open-market sales · 4,235 sh · avg $0.85 · $3,600
Loading xslF345X05/doc4.xml…